Consequently, molecular markers are routinely tested in GBM, markers such as epidermal growth factor receptor (EGFR), O6-methylguanine DNA methyltransferase (MGMT), and tumor suppressor protein TP53 [7]. This evidence concerns the gene EGFR and glioblastoma.